A Checklist of key information and issues patent counsel should consider when conducting patent due diligence for proposed transactions involving innovative therapeutic products such as small molecule drugs and biologics in the pharmaceuticals and biotechnology industries, including patent asset acquisitions, licenses, and collaborations. This Checklist identifies considerations for planning and conducting due diligence to address the target company's freedom-to-operate, patent portfolio, and expected product market exclusivity.